Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04149145
Title Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer
Acronym PARP
Recruitment Withdrawn
Gender female
Phase Phase I
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications
Therapies
Age Groups: adult | senior
Covered Countries


No variant requirements are available.